Skip to main content
Top
Published in: Rheumatology International 7/2016

01-07-2016 | Epidemiology of RMD

The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey

Authors: Fatih Saritas, Salim Donmez, Haner Direskeneli, Omer Nuri Pamuk

Published in: Rheumatology International | Issue 7/2016

Login to get access

Abstract

Takayasu arteritis (TA) is a chronic, inflammatory large vessel vasculitis that affects aorta and its main branches. We aimed to evaluate the incidence and prevalence of TA in the northwestern part of Turkey. We retrospectively evaluated 23 TA patients followed by our clinic. Clinical features, treatments and responses were recorded. Our hospital is the single tertiary referral center for rheumatic diseases for a mixed rural and urban population of 620,447 people for >16 years (306,036 males, 314,411 females). Nineteen of the 23 patients were females (82.6 %) and four were males (17.4 %). The annual incidence rate for TA was 0.34/100,000. The overall prevalence of TA in our region was 3.3/100,000 (95 % CI 1.9–4.8) in individuals >16 years. The most common findings at the time of presentation were blood pressure difference (73 %) and headache (60.4 %). The most common angiographic type was type 1 (12 patients, 52.2 %). Median follow-up period was 48 months (range 10–132). Three (13 %) of the patients had stent replacements to different vascular sites. One patient had an operation for aortic aneurysm, and aortic valve replacement surgery has been made. One patient had renal artery bypass operation. Eleven patients (47.8 %) had recurrency at follow-up period and two patients (8.7 %) died. In northwestern part of Turkey, the annual incidence and prevalence of TA were higher than western population, but similar to East Asian data.
Literature
4.
go back to reference Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yucel AE, Kiraz S, Keser G, Inanc M, Direskeneli H (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1 Suppl 52):S59–S64PubMed Bicakcigil M, Aksu K, Kamali S, Ozbalkan Z, Ates A, Karadag O, Ozer HT, Seyahi E, Akar S, Onen F, Cefle A, Aydin SZ, Yilmaz N, Onat AM, Cobankara V, Tunc E, Ozturk MA, Fresko I, Karaaslan Y, Akkoc N, Yucel AE, Kiraz S, Keser G, Inanc M, Direskeneli H (2009) Takayasu’s arteritis in Turkey—clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(1 Suppl 52):S59–S64PubMed
6.
go back to reference Dreyer L, Faurschou M, Baslund B (2011) A population-based study of Takayasu s arteritis in eastern Denmark. Clin Exp Rheumatol 29(1 Suppl 64):S40–S42PubMed Dreyer L, Faurschou M, Baslund B (2011) A population-based study of Takayasu s arteritis in eastern Denmark. Clin Exp Rheumatol 29(1 Suppl 64):S40–S42PubMed
7.
go back to reference Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr et al (1990) The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33(8):1129–1134CrossRefPubMed
8.
go back to reference Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163CrossRefPubMed Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol 54(Suppl):S155–S163CrossRefPubMed
9.
go back to reference Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, Jeyaseelan L, Lawrence A, Bacon PA, Indian Rheumatology Vasculitis (IRAVAS) group (2013) Development and initial validation of the Indian Takayasu clinical activity score (ITAS2010). Rheumatology 52(10):1795–1801. doi:10.1093/rheumatology/ket128 CrossRefPubMed Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, Jeyaseelan L, Lawrence A, Bacon PA, Indian Rheumatology Vasculitis (IRAVAS) group (2013) Development and initial validation of the Indian Takayasu clinical activity score (ITAS2010). Rheumatology 52(10):1795–1801. doi:10.​1093/​rheumatology/​ket128 CrossRefPubMed
10.
go back to reference Toshihiko N (1996) Current status of large and small vessel vasculitis in Japan. Int J Cardiol 54(Suppl):S91–S98CrossRefPubMed Toshihiko N (1996) Current status of large and small vessel vasculitis in Japan. Int J Cardiol 54(Suppl):S91–S98CrossRefPubMed
11.
go back to reference Waern AU, Andersson P, Hemmingsson A (1983) Takayasu’s arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology 34(5):311–320CrossRefPubMed Waern AU, Andersson P, Hemmingsson A (1983) Takayasu’s arteritis: a hospital-region based study on occurrence, treatment and prognosis. Angiology 34(5):311–320CrossRefPubMed
12.
go back to reference El-Reshaid K, Varro J, Al-Duwairi Q, Anim JT (1995) Takayasu’s arteritis in Kuwait. The Journal of tropical medicine and hygiene 98(5):299–305PubMed El-Reshaid K, Varro J, Al-Duwairi Q, Anim JT (1995) Takayasu’s arteritis in Kuwait. The Journal of tropical medicine and hygiene 98(5):299–305PubMed
14.
go back to reference Park YB, Hong SK, Choi KJ, Sohn DW, Oh BH, Lee MM, Choi YS, Seo JD, Lee YW, Park JH (1992) Takayasu arteritis in Korea: clinical and angiographic features. Heart Vessels Suppl 7:55–59CrossRefPubMed Park YB, Hong SK, Choi KJ, Sohn DW, Oh BH, Lee MM, Choi YS, Seo JD, Lee YW, Park JH (1992) Takayasu arteritis in Korea: clinical and angiographic features. Heart Vessels Suppl 7:55–59CrossRefPubMed
15.
go back to reference Canas CA, Jimenez CA, Ramirez LA, Uribe O, Tobon I, Torrenegra A, Cortina A, Munoz M, Gutierrez O, Restrepo JF, Pena M, Iglesias A (1998) Takayasu arteritis in Colombia. Int J Cardiol 66(Suppl 1):S73–S79CrossRefPubMed Canas CA, Jimenez CA, Ramirez LA, Uribe O, Tobon I, Torrenegra A, Cortina A, Munoz M, Gutierrez O, Restrepo JF, Pena M, Iglesias A (1998) Takayasu arteritis in Colombia. Int J Cardiol 66(Suppl 1):S73–S79CrossRefPubMed
16.
go back to reference Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F (1997) Clinical manifestations of Takayasu arteritis in India and Japan–new classification of angiographic findings. Angiology 48(5):369–379PubMed Moriwaki R, Noda M, Yajima M, Sharma BK, Numano F (1997) Clinical manifestations of Takayasu arteritis in India and Japan–new classification of angiographic findings. Angiology 48(5):369–379PubMed
17.
18.
go back to reference Sharma BK, Sagar S, Singh AP, Suri S (1992) Takayasu arteritis in India. Heart Vessels Suppl 7:37–43CrossRefPubMed Sharma BK, Sagar S, Singh AP, Suri S (1992) Takayasu arteritis in India. Heart Vessels Suppl 7:37–43CrossRefPubMed
19.
20.
go back to reference Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG (1985) Takayasu arteritis: a study of 32 North American patients. Medicine 64(2):89–99CrossRefPubMed Hall S, Barr W, Lie JT, Stanson AW, Kazmier FJ, Hunder GG (1985) Takayasu arteritis: a study of 32 North American patients. Medicine 64(2):89–99CrossRefPubMed
21.
go back to reference Suwanwela N, Piyachon C (1996) Takayasu arteritis in Thailand: clinical and imaging features. Int J Cardiol 54(Suppl):S117–S134CrossRefPubMed Suwanwela N, Piyachon C (1996) Takayasu arteritis in Thailand: clinical and imaging features. Int J Cardiol 54(Suppl):S117–S134CrossRefPubMed
23.
go back to reference Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37(4):578–582CrossRefPubMed Hoffman GS, Leavitt RY, Kerr GS, Rottem M, Sneller MC, Fauci AS (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 37(4):578–582CrossRefPubMed
24.
go back to reference Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929CrossRefPubMed Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, Hoffman GS (1994) Takayasu arteritis. Ann Intern Med 120(11):919–929CrossRefPubMed
25.
go back to reference Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50(7):2296–2304. doi:10.1002/art.20300 CrossRefPubMed Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50(7):2296–2304. doi:10.​1002/​art.​20300 CrossRefPubMed
26.
go back to reference Nakaoka Y, Higuchi K, Arita Y, Otsuki M, Yamamoto K, Hashimoto-Kataoka T, Yasui T, Ikeoka K, Ohtani T, Sakata Y, Shima Y, Kumanogoh A, Yamauchi-Takihara K, Tanaka T, Kishimoto T, Komuro I (2013) Tocilizumab for the treatment of patients with refractory Takayasu arteritis. Int Heart J 54(6):405–411CrossRefPubMed Nakaoka Y, Higuchi K, Arita Y, Otsuki M, Yamamoto K, Hashimoto-Kataoka T, Yasui T, Ikeoka K, Ohtani T, Sakata Y, Shima Y, Kumanogoh A, Yamauchi-Takihara K, Tanaka T, Kishimoto T, Komuro I (2013) Tocilizumab for the treatment of patients with refractory Takayasu arteritis. Int Heart J 54(6):405–411CrossRefPubMed
28.
go back to reference Tyagi S, Verma PK, Gambhir DS, Kaul UA, Saha R, Arora R (1998) Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 21(3):219–224CrossRefPubMed Tyagi S, Verma PK, Gambhir DS, Kaul UA, Saha R, Arora R (1998) Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Intervent Radiol 21(3):219–224CrossRefPubMed
29.
go back to reference Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53(1):93–99. doi:10.1002/art.20928 CrossRefPubMed Reinhold-Keller E, Herlyn K, Wagner-Bastmeyer R, Gross WL (2005) Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Arthritis Rheum 53(1):93–99. doi:10.​1002/​art.​20928 CrossRefPubMed
31.
go back to reference Soto ME, Espinola N, Flores-Suarez LF, Reyes PA (2008) Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol 26(3 Suppl 49):S9–S15PubMed Soto ME, Espinola N, Flores-Suarez LF, Reyes PA (2008) Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol 26(3 Suppl 49):S9–S15PubMed
Metadata
Title
The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey
Authors
Fatih Saritas
Salim Donmez
Haner Direskeneli
Omer Nuri Pamuk
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3445-z

Other articles of this Issue 7/2016

Rheumatology International 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.